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Synovial joint surface defects are important causes of osteo-
arthritis (OA), the most prevalent disease of synovial joints, 
afflicting humans and animals and causing a huge health 
care, welfare, and economic burden.1 A considerable 
amount of research time and effort is directed at devising 
tissue engineering strategies to enhance joint surface defect 
healing, including using cell-based therapies, tissue engi-
neering solutions, and small molecule treatment. However, 
the development of optimal repair strategies is hampered by 
a lack of full understanding of the underlying mechanisms 
by which joint surface defects heal. While a number of stud-
ies exist in rodents and small animals, relatively little is 
known of the healing mechanism of osteochondral defects 
in large animals and, by inference, in man.
Joint surface defects occur either in the cartilage (“chon-
dral” defects) or develop in the cartilage and underlying 
bone (“osteochondral” defects). Osteochondral defects 
have healing capacity if they are small and are believed to 
heal by recruiting nondifferentiated bone marrow–derived 
stromal/stem cells contained in the bone marrow into the 
damaged site. In contrast, chondral defects have a poor 
intrinsic healing capacity. Treatment strategies to heal chon-
dral defects often utilize the bone marrow–derived stromal/
stem cell population by accessing the bone marrow through 
microfracture techniques, which provide cost-effective and 
functional healing in many cases.2-4 The precise contribu-
tion of the stromal stem cell population to the healing of 
osteochondral defects, however, is not known, although 
they may have both a direct and/or indirect (modulatory) 
effect on the repair tissue.
The mechanism by which osteochondral defects heal 
has been described in a number of animals, with most work 
being performed in rabbits. Shapiro et al5. described the 
sequence of healing in 3-mm diameter osteochondral 
defects of the femoral trochlea including an initial fibrin 
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Abstract
Objective. the objective of this study was to describe the mechanism of healing of osteochondral defects of the distal femur 
in the sheep, a commonly used translational model. information on the healing mechanism be useful to inform the design 
of tissue engineering devices for joint surface defect repair. Design. a retrospective study was conducted examining 7-mm 
diameter osteochondral defects made in the distal medial femoral condyle of 40 adult female sheep, comprising control 
animals from 3 separate structures. the healing of the defects was studied at post mortem at up to 26 weeks. Results. 
Osteochondral defects of the distal femur of the sheep heal through endochondral ossification as evidenced by chondrocyte 
hypertrophy and type X collagen expression. Neocartilage is first formed adjacent to damaged cartilage and then streams 
over the damaged underlying bone before filling the defect from the base upward. No intramembranous ossification or 
isolated mesenchymal stem cell aggregates were detected in the healing tissue. No osseous hypertrophy was detected 
in the defects. Conclusions. Osteochondral defects of the medial femoral condyle of the sheep heal via endochondral 
ossification, with neocartilage first appearing adjacent to damaged cartilage. Unlike the mechanism of healing in fracture 
repair, neocartilage is eventually formed directly onto damaged bone. there was most variability between animals between 
8 and 12 weeks postsurgery. these results should be considered when designing devices to promote defect healing.
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repair, mesenchymal cell recruitment, cartilage formation 
starting adjacent to the damaged cartilage, and subsequent 
bone formation. Other work, in larger animals, has 
described cartilage formation adjacent to the residual dam-
aged cartilage. It has been shown that a number of different 
parameters can affect both the efficiency of healing and 
possibly the mechanism of healing, including the position 
of the defect in the knee joint (with both anatomical con-
siderations6,7 and biomechanical differences8 being impor-
tant), the size and depth of the defect,9 and the age of the 
animal.10
The sheep is a commonly used translational model for 
evaluating efficacy of potential treatments for osteochon-
dral defects7,11,12; however, the mechanisms by which osteo-
chondral defects heal in sheep are not described. The aim of 
this study was to describe the temporal sequence of healing 
of 7-mm diameter osteochondral defects of the distal femur 
in the sheep in order to provide key information on those 
processes that are potential targets for therapy.
Materials and Methods
This study received approval from both the Animal Welfare 
and Ethical Review Board, Cambridge University, and the 
UK Home Office (Project Licence Number 70/8165).
Animals
Forty skeletally mature female Welsh Mountain Sheep 
(mean age 3.2 ± 0.8 years) were included in the study, rep-
resenting the control (untreated empty defect) animals from 
3 experiments conducted in our laboratory performed by 
the same surgical team. The experiments were conducted 
12 months apart in 3 cohorts, with the surgical component 
of the work carried out in the same calendar month each 
year. The feed, husbandry, and location of the sheep was the 
same in all animals. The animals were all obtained from the 
same supplier source.
Animal Anesthesia, Preparation, and Surgical 
Technique
General anesthesia was induced with an injection of thio-
pentone (3 mg/kg) and maintenance achieved via inhala-
tional anesthetic of a mixture of isofluorane, nitrous oxide, 
and oxygen. Perioperative analgesia was provided by pre-
operative intramuscular carprofen. Antibiotic prophylaxis 
was given via intramuscular procaine penicillin. The basic 
surgical procedure was identical for all subjects and per-
formed under strict asepsis. Each stifle was physically 
examined for any abnormalities while anesthetized. If any 
gross instability or pathology was found, the animal was 
excluded from participation within the study.
The animal was placed in a dorsal recumbency position 
and, following surgical preparation, the left stifle joint 
opened via a parapatellar approach. Following patella sub-
luxation, a full-thickness 7 mm diameter × 6 mm deep 
osteochondral defect was created in the medial femoral 
condyle using a hand drill. The joint was closed in a stan-
dard fashion. No splints, casts, or immobilization tech-
niques were used in any animal.
Postoperatively, animals were allowed to fully weight 
bear, but kept in small pens for 48 hours to reduce ambula-
tion. All animals were housed indoors for the remaining 
study period in large pens or outdoor in fields, both of which 
permitted normal ambulation. Animals were killed with an 
overdose of injectable anesthetic at 1, 2, 4, 8, 12, 18, and 26 
weeks postsurgery.
Histology
Specimens were decalcified in formic acid/sodium citrate 
over 4 weeks. Following complete decalcification, the speci-
mens were dehydrated through a series of ethanol exchanges 
of increasing concentrations, cleared in xylene, and then 
embedded in paraffin wax. Sections of 8-µm thickness were 
made through the central portion of the defect. Sections were 
stained with toluidine blue and/or Safranin O/Fast Green. A 
semiquantitative histological analysis was performed as 
described by Mainil-Varlet et al.,13 based on a semiquantita-
tive scoring system originally described by O’Driscoll et al.14 
(Table 1). This scoring system has a maximum of 34 points 
and is suitable for demonstrating longitudinal healing of 
osteochondral defects in large animal species.6 Scoring was 
carried out blindly by one observer (FH).
Immunohistochemistry
Immunohistochemistry was performed as described previ-
ously.11 The following primary antibodies were used in this 
study: polyclonal rabbit anti type X collagen (ab58632, 
Abcam, UK, 1 in 200 dilution) and monoclonal mouse anti-
PCNA (DAKO, UK). Type X collagen immunostaining was 
detected with a FITC-conjugated secondary anti-rabbit sec-
ondary antibody (Sigma) and PCNA immunostaining was 
detected with a TRITC-conjugated secondary anti-mouse 
antibody (Sigma). Normal species-specific serum was used 
as a control for each antibody.
Results
Weeks 1 to 2: The Osteochondral Defect Is 
Infilled with Fibrous Tissue
At weeks 1 and 2 after injury, the defect site had filled with 
blood clot and fibrous tissue. The fibrous tissue was organized 
96 CARTILAge 10(1)
with a visible surface layer. At the edge of the damaged articu-
lar cartilage there was a loss of normal architecture (Fig. 1A). 
The normal chondrocyte arrangement was replaced with a 
zone of multicellular chondrocyte “clusters” associated with a 
zone of proteoglycan loss as detected by a reduction in tolu-
idine blue staining at the site.
Weeks 4 to 8: Chondrocytes Form Adjacent 
to the edge of Damaged Cartilage and Bone 
Formation Occurs through endochondral 
Ossification
Between weeks 4 and 8, neocartilage was evident at the top 
edges of the defect immediately adjacent to the edge of the 
remaining cartilage and the cartilage clusters (Figs. 1B and 
2). The cells within the chondrocyte clusters were positively 
stained for PCNA immunoreactivity indicating active 
cycling. Close examination of the tissue suggested that 
these new chondrocytes derived primarily from differentia-
tion of the fibrous tissue clot adjacent to the damaged carti-
lage. However, there was some suggestion that chondrocytes 
at the edges of the damaged cartilage were contributing to 
repair as the orientation of the chondrocytes at the edges of 
the damaged cartilage was toward the neocartilage rather 
than the articular surface (Fig. 2).
From week 4 onwards, the area in which chondrocytes 
were seen was now extending toward the base of the defect 
following the edge of the bone. In defects of increasing age 
these are covered more of the base of the lesion until they 
joined with the chondrocytes arising from the opposite side 
of the lesion by approximately 8 weeks postinjury, effec-
tively lining the exposed bone edges of the defect (Fig. 3). 
Chondrocytes adjacent to the exposed bone edge were 
observed to be larger and more rounded than the new chon-
drocytes that were arising toward the top of the defect with 
a morphology similar to hypertrophic chondrocytes. 
Positive type X collagen staining in these larger chondro-
cytes confirmed their identity as hypertrophic chondrocytes 
(Fig. 3). No evidence of intramembranous ossification was 
detected in any of the sections studied, nor were any carti-
lage “islands” observed within the fibrous tissue away from 
the damaged bone edges.
Weeks 8 to 12: Bone Formation Occurs through 
endochondral Ossification from the Base and 
edges of the Lesion
From week 8 onwards, the healing process continued via a 
process of endochondral ossification with a gradual increase 
in the amount of cartilage within the defect (Fig. 4). The car-
tilage formed within the healing tissue did not show any rec-
ognizable columnar structure at 8 weeks, but by 12 weeks, 
the chondrocytes were beginning to become more structured 
at the edge of the lesion close to the intact cartilage.
Week 18: New Bone Formation Continues and 
Cartilage Is Removed
At week 18, new bone had been formed at the edges and 
base of the defect: at this time point a characteristic “v” 
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shaped healing lesion was observed (Fig. 4). There was evi-
dence of tidemark reformation in the newly formed carti-
lage only at the edges of the defect and the chondrocytes 
within this newly formed cartilage had organized into an 
approximately columnar structure.
Week 26: Healing Is Nearly Complete
Healing was very close to completion at 26 weeks (mean 
histological score 29.6/34). At 26 weeks the defect had been 
filled in with cartilage and bone. The cartilage/bone junc-
tion was positioned at the correct anatomical site within the 
cartilage/bone unit; however, the tidemark was not com-
pletely reformed in any animal. Within the subchondral 
bone underneath the newly formed cartilage, there were 
numerous cartilage remnants remaining that would require 
further resorption and remodeling in future. No evidence of 
osseous hypertrophy was found in any sample studied.
Semiquantitative Analysis
A scoring system suitable for scoring the healing of experi-
mental large animal osteochondral defects was used. This 
scoring system demonstrated that an increase in score corre-
lated with the age of the lesion in these medial femoral con-
dyle lesions (Fig. 5). At 1, 2, and 4 weeks of healing the mean 
healing score (out of a possible total of 34) was 7.6 ± 0.94, 
7.3 ± 1.3, and 8.6 ± 1.7, respectively, with the majority of the 
scoring coming from the integration of the infill material with 
the intact cartilage edges and the underlying bone. At 8 weeks 
of healing the mean score had risen to a mean of 14.6 ± 1.7, 
increasing through a mean of 16.3 ± 2.5 at 12 weeks, a mean 
of 25 ± 0 at 18 weeks, and ending at 26 weeks with a mean of 
29.6 ± 0.63. Between 4 and 8 weeks there was increased 
scoring for tissue infill and surface integrity and then increas-
ing scoring for morphology, structure, and matrix staining in 
the later time points. The tidemark was not fully restored at 
26 weeks in any animal.
Discussion
Healing of joint surface defects remains a clinical challenge 
with significant research endeavor directed at optimizing 
treatment strategies. Understanding the mechanisms behind 
normal healing is vital to inform therapy selection and 
experimental design. In this study, we examined the tempo-
ral sequence of healing within an osteochondral defect 
experimentally created in the medial femoral condyle in the 
sheep and demonstrated that healing of the defect occurs via 
endochondral ossification. The defect size in this study was 
7 mm diameter, which was nearly fully healed within 26 
weeks at this anatomical site (cartilage formed in the appro-
priate place but with some remodeling of subchondral bone 
and tidemark formation still occurring). These data indicate 
that a 7-mm osteochondral defect in the medial femoral 
condyle is able to achieve spontaneous repair and is thus 
considered as below a “critical size”, that is, a defect of a 
size that cannot spontaneously heal.15
Whether or not an experimental defect is small enough 
to achieve spontaneous repair is extremely important in the 
evaluation of therapeutic interventions. Various factors play 
a role in determining whether a defect can spontaneously 
repair, including the anatomical site of the lesion in the joint 
(medial femoral condyle lesions are reported to heal more 
poorly than comparable lesions in the trochlea in the sheep7 
but better in the mini-pig6). In the goat, it has been reported 
that a 6-mm diameter defect in the medial femoral condyle 
does not undergo spontaneous repair16; however, in other 
studies in sheep an 8.3-mm diameter osteochondral defect 
in the medial femoral condyle did not heal after 6 months,9 
suggesting that a defect of approximately 8 mm is the size 
below which spontaneous healing occurs in the medial fem-
oral condyle of adult sheep at 6 months.
These results show that ovine osteochondral healing 
occurs through a defined sequence of events. Initially the 
lesion is filled with a hematoma that then rapidly remodels 
to form a fibrous clot. The first sign of organ-specific tissue 
is the formation of neocartilage adjacent to the damaged 
edges of the cartilage. At this stage in the healing process, 
there was a very similar histological appearance to the heal-
ing defects and similar histological scoring in different 
Figure 1. toluidine blue stained histology sections of the 
defect edge at (A) 1 week and (B) 4 weeks postinjury. in both 
A and B there is loss of proteoglycan at the cartilage edge and 
a loss of the normal architecture of the cartilage. Chondrocyte 
clusters are seen in B. in A, fibrous tissue fills the defect with a 
defined surface layer. in B the fibrous tissue filling the lesion is 
being replaced by rounded chondrocytes. c = cartilage edge; f 
= fibrous tissue in defect; b = bone; s = surface of tissue infill in 
defect; cc = calcified cartilage; ch = chondrocytes in defect; bv = 
blood vessel. Bar = 750 µm.
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animals at the same time postsurgery. This neocartilage is 
then observed, over time, to stream down the edges of the 
defect supported by the underlying bone, coalescing at the 
base of the lesion. New bone is produced circumferentially 
on the edges and base of the lesion via the process of endo-
chondral ossification, as evidenced by the characteristic 
hypertrophic morphology of the chondrocytes and the 
expression of type X collagen. In this sheep osteochondral 
Figure 3. toluidine blue stained histology section of the defect at 8 weeks postinjury. (A) low-power view to show structure of the 
edge (red arrows) and base of the defect (black defect). large rounded cells that are stained more intensely with the toluidine blue 
can be seen lining the edges and base of the defect (white arrows). Bar = 500 µm. (B) Higher power view of box region of A to show 
the appearance of the large rounded cells. Bar = 750 µm. (C) Higher power view of box region of B stained with anti-type C collagen 
antibody with a FitC-labelled secondary antibody. type X collagen is shown in green, confirming the identity of these large rounded 
cells adjacent to the edge and base of the defect as hypertrophic chondrocytes. Bar = 750 µm. c = cartilage edge; f = fibrous tissue in 
defect; b = bone; s = surface of tissue infill in defect; hc = hypertrophic chondrocytes; bv = blood vessel.
Figure 2. Hematoxylin-eosin stained histology sections of the defect edge at 8 weeks postinjury. (A) low-power view to show 
structure of the edge of the defect, Bar = 400microns. (B) Higher power view of box region of A to show presence of multicellular 
chondrocyte clusters and an apparent recruitment of chondrocytes derived from residual cartilage tissue into the new chondrocytes 
being produced in the fibrous tissue infill. Bar = 400microns. (C) Higher power view of box region of B stained with anti-PCNa 
antibody with a tritC-labelled secondary antibody. PCNa activity is shown in red. Bar = 250 µm.
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repair process, no evidence of mesenchymal stem cell 
(MSC) cell condensation was detected in the center of the 
lesion as had been reported in the rabbit.5 As healing pro-
gressed to weeks 8 and 12, there was a wider difference 
between individual animals, at 12 weeks the International 
Cartilage Repair Society scoring varying between 13/34 
(38% “healed”) and 19/34 (56% “healed”), that is, an 18% 
variation in healing scores, primarily due to differences in 
the maturation state of the new cartilage formed. However, 
by 18 weeks and then at 26 weeks there was a marked 
reduction in variability, with all animals scoring similarly. 
These results indicate that, at 26 weeks postsurgery animals 
have a similar histological appearance in 7 mm defects in 
the medial femoral condyle. The increased variation 
between animals at 8 and 12 weeks postsurgery recorded in 
this study suggests that the interpretation of results of 
experiments to document osteochondral healing in the 
medial femoral condyle of sheep with an in-life phase of 8 
to 12 weeks is likely to be complicated by individual differ-
ences and, as such, are not optimal for such investigations.
The origin of the neocartilage and the cartilage that then 
covers the exposed bone surface is not known. The neocar-
tilage originates at the junction between the fibrous clot 
and the damaged cartilage and could arise either from (a) 
the damaged cartilage edge (via activation of cartilage pro-
genitor cells17) or by (b) recruitment and differentiation of 
MSC (released from the bone marrow). PCNA labelling 
indicated that the cells within the fibrous clot and the chon-
drocyte clusters in the damaged cartilage edge are actively 
cycling. Shapiro et al.5 showed, using longitudinal tritiated 
thymidine labelling, that there was significant labelling of 
undifferentiated cells within the fibrous clot, as well as in 
the damaged cartilage, and concluded that the undifferenti-
ated cells primarily contributed to the regeneration of the 
defect. However, some histological sections in this study 
do appear to show a possible contribution of damaged car-
tilage to new cartilage production and further studies are 
required to investigate the precise contribution of the chon-
drocytes and undifferentiated cells in large animal osteo-
chondral healing.
Whatever proves to be the source of the neocartilage, 
this study demonstrates the importance of the damaged tis-
sue in directing healing. Neocartilage is initially formed 
adjacent to the damaged cartilage, indicating that, if not 
directly contributing to the neocartilage production, the 
damaged cartilage is providing an appropriate structural 
support for neocartilage production and/or secreting local 
trophic factors to induce differentiation of undifferentiated 
cells into cartilage. It is known that adult articular cartilage 
is a rich source of morphogenic signals upon injury18,19 and 
cartilage damage induces activation of factors including 
bone morphogeneic proteins (BMP) and Wnt signaling 
proteins within damaged cartilage,20,21 and released into 
the local environment, for example, fibroblastic growth 
factors (FGF).22
Figure 5. a semi-quantitative analysis was performed on 
the histological sections from the medial femoral condyle. an 
increased score correlated with the age of the lesion.
Figure 4. Safranin O stained histology sections of defects at 12 weeks (A), 18 weeks (B), and 26 weeks (C) postinjury. Cartilage is 
stained in red. at 12 weeks a cartilage plug is filling the defect. at 18 weeks the cartilage plug has reduced in size as the base and sides 
of the defect become filled in. By 26weeks the cartilage plug has been replaced by bone and the cartilage remaining at the defect site is 
of a similar depth to the original cartilage. Cartilage remnants are seen within the newly formed bone. Bar = 200 µm.
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The importance of the damaged tissue in directing repair 
is also apparent in the progression of cartilage formation as 
it lines the edge of the damaged bone prior to infilling the 
defect. This observation that endochondral ossification 
occurs upon the damaged bone is unlike the situation during 
fracture repair, where the cartilage callus is laid down 
through endochondral ossification on the intact periosteal 
bone surface rather than on the fractured bone ends,23 dem-
onstrating that osteochondral repair, in these animals at this 
anatomical site, occurs in a dissimilar repair environment to 
that which occurs in fracture repair.
As previously discussed regarding the role of damaged 
cartilage in neocartilage formation, whether the bone is act-
ing as a physical support and/or as a producer of trophic 
mediators for chondrogenesis is not known. Differentiation 
of MSC into chondrocytes is enhanced by increased 
load24,25: we could hypothesize that the junction between 
fibrous tissue and bone experiences increased load relative 
to elsewhere in the fibrous tissue within the defect and that 
the MSC in this area are being influenced by this load dif-
ferential. The repair tissue/bone interface also represents an 
area of altered vascularity and oxygen tension within the 
damaged tissue, and it has been demonstrated, by many 
authors, that these variables, among many others, can affect 
cartilage repair processes.26-28 Clearly, further studies are 
required to fully characterize the role of bone in osteochon-
dral repair.
There have been few studies that describe longitudinal 
observations of healing in large animal models, and to the 
authors’ knowledge, there have been no previous studies of 
longitudinal healing in the medial femoral condyle of the 
sheep. Jackson et al.15 demonstrated, over 52 weeks in a 
goat model, that a 6-mm diameter osteochondral defect fails 
to heal and that progressive, resorption of the defect and 
subsequent collapse of the defect occur. As observed in this 
study, clustering of chondrocytes at the edges of the dam-
aged cartilage was noted but endochondral ossification (as 
determined by toluidine blue staining) was only detected at 
the base of the lesion. Gotterbarn et al.29 reported that dur-
ing healing of the medial aspect of the lateral trochlea ridge 
in mini-pigs endochondral ossification and cartilage stream-
ing was observed at the upper edges of the lesion only.
The results of this study show that endochondral ossifi-
cation is the mechanism by which osteochondral defects 
heal in the sheep. The quantitative analysis of the healing 
shows that there is little variability in the initial stages of 
healing between animals, but that variability is more marked 
between 8 and 12 weeks of repair. However, by the end 
point of this study, 26 weeks, the variability was reduced 
and the appearance of the healing defects similar. In sheep, 
unlike in laboratory animals such as mice, there are far 
more genetic differences between individuals. In this study, 
we have sought to eliminate individual differences as much 
as is practically possible, using female sheep of a similar 
age of the same breed from the same supplier; however, 
these studies were conducted over a 3-year period (drawn 
from the control animals of different studies) and the results 
may be confounded by individual variations.
This finding provides information that may assist the 
design of tissue engineering strategies to heal osteochondral 
defects. However, this finding also poses a potential 
dilemma for strategies that have been used to reduce the 
deleterious osseous overgrowth that can occur during joint 
surface defect repair.30,31 On the basis of the findings 
reported here, future regenerative therapies should be 
directed at maintaining chondrocyte phenotype in the chon-
dral layer of the defect once the subchondral bone plate is 
restored and strategies to inhibit endochondral ossification 
should be used cautiously.
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